| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |